Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review'. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar et al

Affiliations

¹ Rheumatology, Bnai-Zion medical center, Haifa, Israel doronrimar@gmail.com.
² Rheumatology, Bnai-Zion medical center, Haifa, Israel.
³ Department of Immunology, Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Haifa, Israel.
⁴ Department of Immunology, Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.

Free article

Comment

Doron Rimar et al. Ann Rheum Dis. 2022 Oct.

Free article

. 2022 Oct;81(10):e205.

doi: 10.1136/annrheumdis-2020-218790. Epub 2020 Sep 9.

¹ Rheumatology, Bnai-Zion medical center, Haifa, Israel doronrimar@gmail.com.
² Rheumatology, Bnai-Zion medical center, Haifa, Israel.
³ Department of Immunology, Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Haifa, Israel.
⁴ Department of Immunology, Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.

No abstract available

Keywords: biological therapy; cytokines; systemic vasculitis.

Conflict of interest statement

Competing interests: None declared.

Tofacitinib for polyarteritis nodosa: a tailored therapy.
Rimar D, Alpert A, Starosvetsky E, Rosner I, Slobodin G, Rozenbaum M, Kaly L, Boulman N, Awisat A, Ginsberg S, Zilber K, Shen-Orr SS. Rimar D, et al. Ann Rheum Dis. 2016 Dec;75(12):2214-2216. doi: 10.1136/annrheumdis-2016-209330. Epub 2016 Aug 24. Ann Rheum Dis. 2016. PMID: 27558986 No abstract available.
Tocilizumab for the treatment of polyarteritis nodosa: a systematic literature review. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar et al.
Akiyama M, Kaneko Y, Takeuchi T. Akiyama M, et al. Ann Rheum Dis. 2022 Oct;81(10):e204. doi: 10.1136/annrheumdis-2020-218710. Epub 2020 Sep 9. Ann Rheum Dis. 2022. PMID: 32907804 No abstract available.